D.E. Shaw & Co
AVNS

D.E. Shaw & Co’s Avanos Medical AVNS Stock Holding History

D.E. Shaw & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,288
Closed -$210K – 3404
2015
Q4 		$210K Sell
6,288
-1,332
-17% -$41.4K ﹤0.01% 3539
2015
Q3 		$217K Hold
7,620
– – ﹤0.01% 3472
2015
Q2 		$309K Hold
7,620
– – ﹤0.01% 3400
2015
Q1 		$375K Hold
7,620
– – ﹤0.01% 3207
2014
Q4 		$346K Buy
+7,620
New +$299K ﹤0.01% 3563

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

D.E. Shaw & Co's AVNS Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Avanos Medical (AVNS) stake by 58% in Q2 2026, selling an estimated $9.15M and leaving 280,729 shares worth $6.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2144.

D.E. Shaw & Co first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $30.1M in Q1 2022. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • D.E. Shaw & Co held 280,729 shares of Avanos Medical worth $6.98M as of Q2 2026.
  • D.E. Shaw & Co sold 390,684 Avanos Medical shares in Q2 2026, an estimated $9.15M.
  • Avanos Medical made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2144 holding.
  • D.E. Shaw & Co first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
  • D.E. Shaw & Co's Avanos Medical position peaked at $30.1M in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.